We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Metastasis Triggered by Two Signaling Molecules

By Biotechdaily staff writers
Posted on 15 Jul 2002
A study has found that the sequential activity of two signaling molecules, Smad2 and H-ras, is required for a tumor to spread to other parts of the body. More...
The study was published in the July 1, 2002, advance online issue of Nature Cell Biology.

Using a mouse tumor cell line, investigators from the University of California, San Francisco (USA; www.ucsf.edu), showed that activating Smad2 can prompt the migration of tumor cells to distant sites. Increasing the amount of H-ras converts epithelial-like cells into mobile fibroblastoid-like cells. A further increase of Smad2 allows the cells to enter blood vessels and migrate to other tissues.

"Our results provide a new view of ras and Smad cooperating to promote tumor development,” the researchers said. "We propose that differing threshold levels of Smad2 and Ras activity are important for accomplishing the sequential steps of metastasis and suggest that this pathway will provide important targets for drug discovery, which should lead to new possibilities for the control of tumor spread.”



Related Links:
Univ. of CA, SF

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.